Dr. Davies is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161Fax+1 713-563-3424
Education & Training
- University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 2004 - 2007
- Massachusetts General HospitalResidency, Internal Medicine, 2001 - 2004
- McGovern Medical School at UTHealthClass of 2001
Certifications & Licensure
- FL State Medical License 2021 - Present
- WA State Medical License 2023 - 2026
- AL State Medical License 2023 - 2025
- AZ State Medical License 2023 - 2025
- GA State Medical License 2023 - 2025
- LA State Medical License 2023 - 2025
- MS State Medical License 2023 - 2025
- Join now to see all
Clinical Trials
- An Open-Label Phase II Study of the Combination of GSK2118436 and GSK1120212 in Patients With Metastatic Melanoma Which is Refractory or Resistant to BRAF Inhibitor Start of enrollment: 2012 Sep 01
- Testing the Addition of Navitoclax to the Combination of Dabrafenib and Trametinib in People Who Have BRAF Mutant Melanoma Start of enrollment: 2014 Mar 24
- CNS and Extracranial Tumor Tissues, CSF, and Blood From Patients With Melanoma Brain Metastases Start of enrollment: 2014 Aug 12
Publications & Presentations
PubMed
- Imipridones inhibit tumor growth and improve survival in an orthotopic liver metastasis mouse model of human uveal melanoma.Chandrani Chattopadhyay, Janos Roszik, Rajat Bhattacharya, Md Alauddin, Iqbal Mahmud
British Journal of Cancer. 2024-12-01 - Melanoma Brain Metastasis: Biology and Therapeutic Advances.Merve Hasanov, Yusuf Acikgoz, Michael A Davies
Hematology/oncology Clinics of North America. 2024-10-01 - 1 citationsA protein expression atlas on tissue samples and cell lines from cancer patients provides insights into tumor heterogeneity and dependencies.Jun Li, Wei Liu, Kamalika Mojumdar, Hong Kim, Zhicheng Zhou
Nature Cancer. 2024-10-01
Journal Articles
- Author Correction: Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable MelanomaJanice N Cormier, Ehab Hanna, Padmanee Sharma, Jennifer A Wargo, Isabella C Glitza, Sapna P Patel, Adi Diab, Jeffrey E Lee, Richard Royal, Randal Weber, Patrick Hwu, J..., Nature
- Publisher Correction: Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable MelanomaScott Woodman, Alexander J Lazar, Michael A Davies, Neil Gross, Sapna P Patel, Isabella C Glitza, Ehab Hanna, Stephen Y Lai, Richard Ehlers, Amy Hessel, Padmanee Sharm..., Nature
- Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable MelanomaRichard Royal, Alexander J Lazar, Adi Diab, Sapna P Patel, Jeffrey E Lee, Padmanee Sharma, Patrick Hwu, Randal Weber, Jeffrey Gershenwald, Carol Lewis, Richard Ehlers,..., Nature
- Join now to see all
Press Mentions
- Physician-Scientist Focused on Improving Brain Metastases TreatmentFebruary 17th, 2023
- New Cell-Based Therapy for Melanoma Is More Effective Than Existing Treatment, Trial SaysSeptember 10th, 2022
- New Cell-Based Therapy for Melanoma More Effective Than Existing Treatment, Trial FindsSeptember 10th, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: